Nonoral Preparation Having Three-Layer Structure

专利摘要:
An object of the present invention is to impart a function other than sustained release, that is, a target and an adhesive function to micro or millicapsules and a film, and to encapsulate the target substance to be sealed at an efficiency of almost 100%. According to the present invention, a base layer made of a polymer; A holding layer for containing a target substance selected from drugs, perfumes, mosquito repellents, pigments, cells or antigens; And a parenteral solvent having a three-layer structure of the surface layer, wherein the holding layer is present between the base layer and the surface layer.
公开号:KR20030023868A
申请号:KR1020027016065
申请日:2001-05-24
公开日:2003-03-20
发明作者:칸지 타카다
申请人:칸지 타카다；
IPC主号:

专利说明:

Parenteral preparation having a three-layered structure {Nonoral Preparation Having Three-Layer Structure}
[2] In order to achieve stabilization of unstable chemicals or to impart sustained release, conventional microcapsules are prepared from a W / O type, O / W type, or W / O / W type emulsion by a liquid drying method. In the microcapsule manufacturing method, only an almost spherical uniform microcapsule can be produced.
[3] We first invented a uniform microcapsule or millicapsule with a three-layered structure as a pharmaceutical formulation (Kanji Takada, International Application No. PCT / JP99 / 06602, An oral formulation for gastrointestinal drug delivery). In order to mass-produce such microcapsules or millicapsules, it is impossible in the above-mentioned conventional manufacturing method. In addition, it is also impossible to increase the encapsulation rate of the target material to almost 100% by the conventional manufacturing method. According to the conventional manufacturing method of microcapsules, not only the sealing rate of the target substance encapsulated in the microcapsules is low, but also the yield is further reduced by sizing because the variation of the terminal size of the obtained microcapsules is large.
[4] A number of microcapsules preparations have been developed to this day, including in-liquid drying of W / O / W emulsions. However, what can be produced by this technique is limited to uniform almost spherical microcapsules. In addition, in the conventional method, it was very difficult to encapsulate the target substance into the microcapsules at a sealing rate of 100%.
[1] The present invention relates to a non-uniform microcapsule, milli-capsule or film-like parenteral preparation consisting of three layered structures which can achieve the target material at nearly 100% encapsulation efficiency and a method for producing the same.
[5] The inventors first invented oral mucoadhesive preparations consisting of a three-layered structure (Kanji Takada, International Application No. PCT / JP99 / 06602, An oral formulation for gastrointestinal drug delivery). This oral mucoadhesive agent mainly relates to a film agent or a nonuniform micro or millicapsule agent for use in oral administration. However, in order to mass-produce a drug containing a target substance selected from drugs other than oral medicines, fragrances (fragrances), mosquito repellents, cells (for example, artificial cells, etc.) or antigens, the encapsulation rate is increased to make it uneven. It is necessary to confirm the method of manufacturing a microcapsule, a millicapsule, or a film agent.
[6] In other words, the problem to be solved by the present invention is to give microcapsules, millicapsules and films with functions other than sustained release, that is, targetability and adhesiveness, and the target substance to be encapsulated with an efficiency of almost 100%. It is to provide a formulation which can be enclosed and a method for producing the same. Another object of the present invention is to provide a method for mass production of the above formulation.
[7] MEANS TO SOLVE THE PROBLEM As a result of earnestly examining in order to solve the said subject, it is a nonuniformity characterized by having a three-layer structure of a base layer, a carrying layer for containing a target substance, and a surface layer. It has been found that the above problems can be achieved by producing a microcapsule, millicapsules or film agent, and the present invention can be completed.
[8] In other words, according to the present invention, a base layer made of a polymer; A holding layer for containing a target substance selected from drugs, perfumes, mosquito repellents, pigments, cells or antigens; And a parenteral preparation having a three-layer structure of the surface layer, wherein the holding layer is present between the base layer and the surface layer.
[9] In the first aspect of the present invention, the base layer, the holding layer, and the surface layer are each in the form of a film, and the above three layers are laminated and formed.
[10] In the second aspect of the present invention, the base layer has a hemispherical shape, a holding layer is present in the internal space of the electric hemisphere shape, and the surface layer covers the opening portion of the electric hemisphere shape.
[11] Preferably, the polymer of the base layer is a water insoluble polymer or biodegradable polymer.
[12] Preferably, the base layer is a film composed of ethyl cellulose, cellulose acetate, polylactic acid, polyglycolic acid copolymer, hydroxypropylmethylcellulose phthalate, or methacrylic acid copolymer-S (Eudragit S).
[13] Preferably, the target substance contained in the holding layer is granulocyte growth factor (G-CSF), erythropoietin, interleukin, growth hormone, calcitonin, insulin, orange oil, N, N-diethyltoluamide, botulinum toxin Or pancreatic langerhans island.
[14] Preferably, the surface layer consists of a polymer that dissolves in response to pH, a water insoluble polymer, or a biodegradable polymer.
[15] In addition, according to the present invention, forming a micron size or millimeter sized bone in the base layer consisting of a film prepared using a water-insoluble polymer or a biodegradable polymer;
[16] Filling a bone of electric bone with a target substance selected from drugs, flavors, mosquito repellents, pigments, cells or antigens;
[17] Sealing the bone by adhering a surface layer consisting of a polymer film coated with an adhesive to the top of the electrical bone; And,
[18] Provided are a preparation method for parenteral preparations comprising the step of cutting the film of the three-layer structure obtained in the past to a micro or millimeter size, and a parenteral preparation prepared by the electric preparation method.
[19] In addition, according to the present invention, a mixture of a target substance and an adhesive substance selected from drugs, perfumes, mosquito repellents, pigments, cells or antigens on a base layer made of a film prepared using a water insoluble polymer or a biodegradable polymer is prepared. Applying;
[20] Applying a surface layer resulting from the polymer film on top of the applied mixture; And,
[21] There is provided a parenteral preparation prepared by a method for producing a parenteral preparation and an electric preparation method comprising pressing a heated punch having a micro or millimeter diameter to simultaneously cut and cut the upper and lower polymer films.
[22] Best Mode for Carrying Out the Invention
[23] Parenteral preparations having a three-layered structure of the present invention, for example, first make a base layer having a millimeter or micro sized bone, and then from drugs, flavors, mosquito repellents, pigments, cells or antigens. The target material to be selected is added, and finally, a cap is made using an upper film coated with a pressure-sensitive adhesive, and mass production is possible by cutting it into a micro or millimeter size.
[24] In addition, when the target substance has heat resistance, the target substance selected from drugs, perfumes, mosquito repellents, pigments, cells or antigens on the film (base layer) manufactured using a water insoluble polymer, a biodegradable polymer, or the like is sticky. It is possible to lay out and apply with a substance, apply various polymer films (surface layer) on it, and press with a punch having a heated micro or millimeter size aperture, and press and cut the upper and lower polymer films to produce micro, milli-capsule or film. Do.
[25] The parenteral preparation of the present invention has a three-layer structure consisting of a base layer, a holding layer and a surface layer, and is preferably supplied in the form of a nonuniform microcapsule, millicapsule or film.
[26] The base layer is a bowl-shaped micro or millimeter-sized container made of a water-insoluble polymer and a biodegradable polymer required to protect the target material contained therein or to control release.
[27] The holding layer is provided in the micro or millimeter-sized container, and a space for encapsulating a target substance selected from drugs, perfumes, mosquito repellents, pigments, cells or antigens (vaccines) is secured.
[28] In order to raise the retention of a target substance in a holding layer, a cellulose sponge, tissue paper, a fiber, etc. can be put.
[29] The surface layer is a film made of various polymers for preventing leakage of a target substance contained in a micro or mille container or to give specificity to a target site. For example, hydroxypropylmethylcellulose phthalate (HP55), methacrylic acid copolymer L (Eudragit L), methacrylic acid copolymer LD (Eudragit LD), methacrylic acid copolymer S (Eudragit S) Polymer films).
[30] Although the thickness of a surface layer is not specifically limited, For example, it is about 10-100 micrometers, Preferably it is about 20-70 micrometers, More preferably, it is about 30-50 micrometers.
[31] The polymer constituting the base layer is ethyl cellulose, aminoalkyl methacrylate copolymer E (Eurdragit E), amino alkyl methacrylate copolymer RS (Eurdagit RS), cellulose acetate, chitin, chitosan, polylactic acid, etc. Biodegradable polymers are used.
[32] Although the film thickness of a base layer is not specifically limited, For example, it is about 10-100 micrometers, Preferably it is about 20-70 micrometers, More preferably, it is about 30-50 micrometers.
[33] The base layer can be used even if it is a complete film or a rib on the film. In the case of bone, it is desirable to use a micro or millimeter container with a depth of 10 to 1000 microns and a diameter of 20 to 8000 microns. In the case of manufacturing from a film, the polymer is dissolved in an organic solvent such as ethanol and cast into a Teflon framework, and the solvent is evaporated to remove the film. For example, 550 mg of ethyl cellulose and 25 µl of triethyl citrate are dissolved in 5 ml of a mixture of methylene chloride: methanol (4: 1), and cast onto Teflon plate. The finished film is regularly placed on a metal template formed with a myriad of micron or milli-terminal projections, left for a few hours under high temperature heating, cooled, micro 20 or 8,000 microns in depth, or 10 to 1000 microns deep. Make a millie container.
[34] Two methods, solid phase method and liquid phase method, are available for adding a target substance selected from drugs, flavors, mosquito repellents, pigments, cells or antigens in micro or milliliter containers.
[35] Examples of the solid phase method include carboxyl vinyl polymers, polyacrylic acid and acrylic acid octyl ester copolymers, acrylic acid-2-ethylhexyl vinylpyrrolidone copolymers, acrylic acid silica fibrin copolymers, gum arabic, polyvinyl alcohol, Polyvinyl pyrrolidone, methyl cellulose, hydroxypropyl methyl cellulose, polyisoprene, polyacrylic acid, sodium polyacrylate, arginine acid, alpha succinate, carboxymethyl ethyl cellulose, carboxymethyl starch sodium, crystal cellulose, cyclodextrin, etc. The adhesive polymer and rubber are mixed and a certain amount is fixed in a micro or milliliter container.
[36] As the liquid phase method, a solvent for dissolving water or the like is added to the target substance and the above-mentioned pressure-sensitive adhesive, and once filled with a nano-injector and a micro-injector as a solution, the solution is filled in a micro or milliliter container in a fixed state.
[37] The surface layer is dissolved in response to the pH of the environment, for example, hydroxypropyl methyl cellulose phthalate (HP-55), hydroxypropyl methyl cellulose trimellitin acid (HPMCT), methacrylic acid copolymer L (Eudragit L), About 30 thickness made with polymers such as methacrylic acid copolymer-LD (EudragitLD), methacrylic acid copolymer S (Eudragit S), aminoalkyl methacrylate copolymer E (Eudragit E), polyvinyl acetal diethylamino acetate You may use a ~ 50 micron film. For example, 225 mg of HP-55 (manufactured by Xinwol Chemical Co., Ltd.) and 25 µl of triethyl citrate were added to dissolve 5 ml of a methylene chloride: methanol (4: 1) mixed solution, and a film prepared by casting onto 10 × 10 cm wide Teflon plate. to be. As an example, 25 µl of triethyl citrate was added to 225 mg of Eudragit S100 or Eudragit L100, and 5 ml of methylene chloride: methanol (1: 1) solution was added to dissolve the same. The film produced by casting on a Teflon plate is used.
[38] If the surface layer does not specify an attachment site and simply controls the release rate, a thick film of 30 to 60 micron film made of a water-insoluble polymer such as ethyl cellulose or a biodegradable polymer such as polylactic acid You can also use In addition, films made of water-insoluble polymers such as aminoalkyl methacrylate copolymer RS (Eudragit BS) and vinyl acetate resin can be used.
[39] Carbopol, Polycarbophil, Hibiswako, Noveon, Sodium Polyacrylate, Poly-N-Vinyl Acetamide (PNVA) ), Polyvinyl alcohol, acrylic acid and acrylic acid octyl copolymer, acrylic acid 2-ethylhexyl vinyl vinylpyrrolidone copolymer, acrylic acid silica fibrin copolymer resin, gum arabic, alpha starch, camelos, hydroxyethyl cellulose, hydroxy A solution of a pressure-sensitive adhesive such as oxypropyl cellulose, methacrylic acid, n-butyl copolymer, and the like is applied to the surface layer film and adhered to a micro or millimeter container containing the target substance.
[40] If the target material has heat resistance, it is not necessary to prepare the base layer in the form of a micro or millimeter container. On the film (base layer) prepared using a water-insoluble polymer and a biodegradable polymer, etc., the target substance is mixed with the above-described adhesive, the surface film is coated thereon, and the edge is processed with a micro or millimeter size aperture. It is possible to manufacture micro or millicap capsules and films by pressing and cutting the upper and lower polymer films by applying a method such as applying rotation with a heated punch. In addition, by heating the plates arranged from tens to hundreds with an edge-punched punch, a film made of a three-layer structure is placed, and a roller made of Teflon is transferred to squeeze and cut the upper and lower polymer films to form micro, milli-capsule or It is possible to produce a film. Alternatively, the polymer film for the base layer and the surface layer is cut to overlap with a width of 3 mm and a length of 1 m, and then left and right are heated and compressed to a width of about 0.2 mm. Then, 0.2 mm wide crimps are provided at about 330 locations at 3 mm intervals. It can also be prepared by cutting it into about 330 pouches, filling the mixture of the target material and the tacky polymer, and then sealing the top by thermocompression.
[41] In the case of filling a target material by forming a micro or milliliter container in the base layer, it is called individual micro or milli capsules which are separated, and is cut individually by mechanical or laser to produce non-uniform micro or milli capsules and films. .
[42] Absorption accelerators such as citric acid, polyoxyethylene-cured castor oil derivatives, capric acid, and ulsodeoxycholine acid, in addition to drugs produced by recombinant gene production such as G-CSF, insulin, calcitonin, erythropoietin, growth hormone, etc. By formulating the compound, the bioavailability of protein / peptide drug administration can be enhanced.
[43] Perfumes, mosquito repellents, cosmetic pigments, etc. are mixed with the adhesive polymer to form a holding layer, which is sandwiched between the surface layer and the base layer, and microcapsule, millicapsule, and film are formed by sticking and puncturing with a heated punch. It is possible.
[44] By putting live cells such as pancreatic Langerhans island in a micro or milliliter container, an artificial organ can be made with a high encapsulation rate of almost 100%. In addition, by placing antigens such as botulinum toxin and DNA vaccines in a micro or milline container, micro or milli capsules of the vaccine can be produced at high inclusion rates.
[45] The parenteral preparation of the present invention can be administered to a subject or a subject by a route other than oral, for example, rectal, vaginal, intravenous, intramuscular, subcutaneous, orbital, intraperitoneal, intranasal, etc. It can be administered by route or through the skin, for example using a skin patch or the like.
[46] The present invention will be described in more detail with reference to the following examples, which are not intended to limit the scope of the present invention.
[47] Example 1
[48] 5 ml of a mixture of methylene chloride and ethanol (4: 1) was added and dissolved in 550 mg of ethyl cellulose (EC) and 25 µl of triethyl citrate. The obtained solution was poured on a 10 x 10 cm Teflon plate to evaporate the solvent to prepare an EC film having a thickness of about 50 µm. On an aluminum plate of 9 cm in length and 3.5 cm in width, 20 × 50 = 1000 projections having a diameter of 200 μm and a height of 100 μm were applied to a metal mold, which was thinly coated with heated paraffin, heated to 90 ° C., and an EC film was placed thereon. , 10kg of iron balls were put up and pressed for 30 minutes.
[49] After cooling, EC type films contained in the removed bones were prepared. Each 50 n1 of a solution of N, N-diethyltriamide (a commercially available from Tokyo Kasei), which is a repellent for malaria mosquitoes, was injected into 100 bones using a nanoinjector. The 2% Hibiswaco-103 aqueous solution was apply | coated to the EC film manufactured as mentioned above as an adhesive agent, and was added to the EC film. The 2% Hibiswaco-103 aqueous solution was apply | coated once again as an adhesive agent on the EC membrane film added. 300 mg of Eudragit L-100, a polymer dissolved at pH 6.0, and 25 µl of triethyl citrate were dissolved in 10 ml of a mixed solution of methyl chloride and ethanol (4: 1), and a film made by pouring onto a 10 × 10 cm Teflon plate was added. The microcapsules punched out by the metal punch of the same size as the 25G needle previously heated at 90 degreeC were taken out, and the capsule of the sustained release malaria mosquito repellent which adhered to skin for a long time was obtained.
[50] Example 2
[51] 5 ml of a mixture of methylene chloride and ethanol (4: 1) was added to 550 mg of Eudragit RS and 25 µl of triethyl citrate. The resulting solution was poured into 10 x 10 cm Teflon phase, and the solvent was evaporated to prepare Eudragit RS film having a thickness of about 50 mu m. On an aluminum plate of 9 cm in length and 3.5 cm in width, 20 × 50 = 1000 projections having a diameter of 200 μm and a height of 100 μm were applied to a metal mold prepared by thinly applying liquid paraffin and heated to 90 ° C., and a Eudragit RS film was placed thereon. Topped with 10 kg of iron balls and pressed for 30 minutes.
[52] After cooling, an Eudrgit RS film produced in the interior of the removed bone was obtained. 50 nl of orange oil was injected into 1000 bones using a nanoinjector. As the surface layer film, a film of Eudragit L-100 was used. To the film of Eudragit L-100, an aqueous solution of 2% Hibizwaco-103 was applied as an adhesive, and then attached onto the Eudragit S film. The microcapsules punched out by the metal punch of the same size as the 25G needle previously heated at 90 degreeC were taken out, and the slow-release microcapsule containing an fragrance | flavor was obtained.
[53] Example 3
[54] To 150 mg of polyoxinethylene-cured castor oil derivative (HC0-60), 200 mg of citric acid, and 150 mg of Hibiswako-103, 5 ml of water was added and mixed in a mortar, and then the recombinant human granulocyte growth factor G- 200 μl CSF (500 μg / ml) was added and mixed. It was applied onto an ethyl cellulose film of 10 × 10 cm size. After standing at room temperature for 2 hours, a film was attached to the surface layer. As a surface film, the film made from HP-55 which is a polymer melt | dissolving in pH 5.5 was used. The milli-capsule punched out by the metal punch of 3.0 mm of diameter heated previously at 90 degreeC was taken out. After lubricating with silicate magnesium powder, it was filled into commercially available 00 size gelatin capsules. If necessary, the pores were filled with sesame oil or the like and then sealed with a band-seal.
[55] Example 4
[56] Pancreatic Langerhans Island of rats was obtained by a conventional method (see Takayama Oyama, transplantation 34 (4): 174-185, 1999). A 1% carboxymethyl cellulose solution in which pancreatic rancher islets were filled into a micro injector. The pancreatic langeshansum was injected into a microinjector into a bone having a diameter of 2 mm and a depth of 1 mm formed on an EC film prepared according to Example 1. An HP-55 film prepared according to Example 1 was prepared. The adhesive prepared by Hibiswaco-103 was applied with an HP-55 film, and adhered with an EC film containing living cells in a micro container. The circumference | surroundings of a micro container were cut out by the laser beam on the circle of about 3 mm in diameter, and the nonuniform milli capsule which has a three layered structure was obtained.
[57] The present invention makes it possible to provide non-uniform micro or millicapels and films having a three-layer structure capable of encapsulating a target substance at an efficiency of almost 100%. That is, according to the present invention, it is possible to mass-produce a formulation having a three-layer structure by pressing and piercing the polymer film of two layers of the surface layer and the base layer to which the target substance is sandwiched.
[58] The target substance that can be encapsulated can be selected from drugs, perfumes, mosquito repellents, pigments (particularly cosmetic pigments, etc.), cells (live cells, etc.) or antigens, regardless of the liquid or solid.
[59] By selecting various polymer films having different dissolved pH thresholds on the surface layer, it is also possible to make the attachment site targetable, or to apply it to the skin surface for a long time. In addition, it is possible to adhere to ophthalmic mucosa, nasal mucosa, or intraoral mucosa.
[60] It is possible to mass produce nonuniform micro or millicapsules and films with a three-layer structure. By selecting the target substance contained in it, it is applicable for various uses. For example, the use of a medicament can improve the bioavailability of the recombinant protein-peptide drug. In addition, vaccines, artificial organs, sustained-release eye drops, sustained-release eye drops and the like can be developed. In the case of cosmetics, if a cosmetic pigment is selected as the target substance, lipsticks, eyeshadows, etc., which are hard to be removed, can be developed. If insect repellents are used, sustained-release mosquito repellents etc. which adhere to the skin for a long time can be developed.
[61] According to the present invention, a nonuniform microcapsule agent, a millicapsule agent, or a film agent composed of a three-layer structure is provided, and at the same time, a mass production method thereof has been established.
[62] According to the present invention, a micro or milli-capsule container is prepared in the base layer, and the target substance is encapsulated therein, so that the target substance can be encapsulated with an efficiency of almost 100%. In addition, since a polymer film having various properties is used as a surface layer film and coated, it is possible to have a function other than sustained release, ie, target site directivity, by micro or millicapsules. Although the sealing rate decreases a little, it is possible to mass-produce the formulation of the present invention by inserting the target object into the adhesive layer, sandwiching it between the surface layer and the base layer, and then hot pressing and cutting with a punching machine and a laser light.

权利要求:
Claims (11)
[1" claim-type="Currently amended] A base layer made of a polymer; A holding layer for containing a target substance selected from drugs, perfumes, mosquito repellents, pigments, cells or antigens; And a three-layer structure of the surface layer, wherein the retaining layer is present between the base layer and the surface layer.
[2" claim-type="Currently amended] The method of claim 1,
The base layer, the holding layer and the surface layer are each in the form of a film, characterized in that the three layers formed by laminating
Parenteral solvents.
[3" claim-type="Currently amended] The method of claim 1,
The base layer has a hemispherical shape, a holding layer is present in the interior space of the electric hemisphere shape, and the surface layer covers the opening portion of the electric hemisphere shape.
Parenteral solvents.
[4" claim-type="Currently amended] The method according to any one of claims 1 to 3,
Characterized in that the polymer of the base layer is a water-insoluble polymer or a biodegradable polymer
Parenteral solvents.
[5" claim-type="Currently amended] The method according to any one of claims 1 to 4,
The base layer is a film consisting of ethyl cellulose, cellulose acetate, polylactic acid, polyglycolic acid copolymer, hydroxypropylmethyl cellulose phthalate or methacrylic acid copolymer-S (Eudragit S)
Parenteral solvents.
[6" claim-type="Currently amended] The method according to any one of claims 1 to 5,
The target substance contained in the holding layer is granulocyte growth factor (G-CSF), erythropoietin, interleukin, growth hormone, calcitonin, insulin, orange oil, N, N-diethyltoluamide, botulinum toxin or pancreatic langerhans. Characterized by
Parenteral solvents.
[7" claim-type="Currently amended] The method according to any one of claims 1 to 6,
The surface layer is made of a polymer, a water insoluble polymer or a biodegradable polymer that dissolves in response to pH.
Parenteral solvents.
[8" claim-type="Currently amended] Forming a micron size or millimeter sized bone in a base layer made of a film prepared using a water insoluble polymer or a biodegradable polymer;
Filling a bone with a target substance selected from drugs, flavors, mosquito repellents, pigments, cells or antigens;
Sealing the bone by adhering a surface layer consisting of a polymer film coated with an adhesive to the top of the electrical bone;
Method for producing a parenteral solvent comprising the step of cutting the film of the three-layer structure obtained in the past to micro or millimeter size.
[9" claim-type="Currently amended] A parenteral solvent prepared by the method of claim 8.
[10" claim-type="Currently amended] Applying a mixture of a sticky substance with a target substance selected from drugs, perfumes, mosquito repellents, pigments, cells or antigens on a base layer made of a film prepared using a water insoluble polymer or a biodegradable polymer;
Coating a surface layer made of a polymer film on top of the applied mixture; And,
A method for producing a parenteral solvent comprising the steps of pressing and cutting the upper and lower polymer films at the same time by pressing with a heated punch having a micro or millimeter size aperture.
[11" claim-type="Currently amended] A parenteral preparation prepared by the method of claim 10.

类似技术:

---

公开号 | 公开日 | 专利标题

---

Larrañeta et al.2016|Microneedles: a new frontier in nanomedicine delivery

---

Waghule et al.2019|Microneedles: A smart approach and increasing potential for transdermal drug delivery system

---

Hines et al.2013|Poly | acid− controlled-release systems: experimental and modeling insights

---

Srivastava et al.2015|Polymers in drug delivery

---

US9675789B2|2017-06-13|Embeddable micro-needle patch for transdermal drug delivery and method of manufacturing the same

---

JP5472770B2|2014-04-16|Short melting microneedle

---

Wang et al.2017|Recent advances in the design of polymeric microneedles for transdermal drug delivery and biosensing

---

Hong et al.2013|Dissolving and biodegradable microneedle technologies for transdermal sustained delivery of drug and vaccine

---

Sinha et al.2004|Chitosan microspheres as a potential carrier for drugs

---

Jalil et al.1990|Biodegradable poly | and poly | microcapsules: problems associated with preparative techniques and release properties

---

Singh et al.2005|Optimizing drug delivery systems using systematic" design of experiments." Part II: retrospect and prospects

---

US5407609A|1995-04-18|Microencapsulation process and products therefrom

---

JP4829497B2|2011-12-07|Rapidly dissolving microperforators and other applications for drug delivery

---

CA2106952C|2003-01-21|A single dose vaccination system

---

SHINGADE2012|Review on: recent trend on transdermal drug delivery system

---

EP0954291B1|2005-12-28|Soluble form osmotic dose delivery system

---

US5458888A|1995-10-17|Controlled release tablet formulation

---

AU683044B2|1997-10-30|Process for preparing controlled release pharmaceutical forms and the forms thus obtained

---

ES2205177T3|2004-05-01|Powder composition for nasal administration.

---

ES2267107T3|2007-03-01|Formulation of controlled release for hydrosoluble drugs in which one step is formed in situ.

---

Gabor1999|Ketoprofen-poly | microspheres: influence of manufacturing parameters and type of polymer on the release characteristics

---

Pegoraro et al.2012|Transdermal drug delivery: from micro to nano

---

US4434153A|1984-02-28|Drug delivery system comprising a reservoir containing a plurality of tiny pills

---

EP2007360B1|2014-11-26|Controlled release delivery device comprising an organosol coat

---

US3916899A|1975-11-04|Osmotic dispensing device with maximum and minimum sizes for the passageway

同族专利:

---

公开号 | 公开日

---

US7695729B2|2010-04-13|

---

EP1284137A4|2007-11-07|

---

AU2001260612B9|2005-06-09|

---

JP4990465B2|2012-08-01|

---

EP1284137A1|2003-02-19|

---

EP1284137B1|2010-12-01|

---

WO2001089486A1|2001-11-29|

---

CA2410293A1|2002-11-26|

---

DE60143571D1|2011-01-13|

---

AT489946T|2010-12-15|

---

CN1444474A|2003-09-24|

---

US20030157140A1|2003-08-21|

---

KR100772025B1|2007-10-31|

---

CN1245960C|2006-03-22|

---

AU6061201A|2001-12-03|

---

AU2001260612B2|2005-04-28|

引用文献:

---

公开号 | 申请日 | 公开日 | 申请人 | 专利标题

---

法律状态:
2000-05-26|Priority to JPJP-P-2000-00156227

---

2000-05-26|Priority to JP2000156227

---

2001-05-24|Application filed by 칸지 타카다

---

2001-05-24|Priority to PCT/JP2001/004355

---

2003-03-20|Publication of KR20030023868A

---

2007-10-31|Application granted

---

2007-10-31|Publication of KR100772025B1

优先权:

---

申请号 | 申请日 | 专利标题

---

JPJP-P-2000-00156227|2000-05-26|

---

JP2000156227|2000-05-26|

---

PCT/JP2001/004355|WO2001089486A1|2000-05-26|2001-05-24|Nonoral preparation having three-layer structure|